
Zydus Lifesciences Share Price in 2025: Chart, Monthly Trends, & Analysis


How did Zydus Lifesciences shares perform in 2025?
Let's find out!
Zydus Lifesciences share price in 2025 was ₹983.2 Its price on 1st January 2025 was ₹971, and by 31st December 2025 it moved to ₹983.2, giving a positive return of 1.25% for the year.
Zydus Lifesciences Share Open, High, Low, and Close prices for the Year 2025 are as follows:
Open | High | Low | Close |
---|---|---|---|
₹971 | ₹1,027.95 | ₹795 | ₹983.2 |
1st Jan 2025 | Occured in Jan 2025 | Occured in Apr 2025 | 31st Dec 2025 |
This page will help you understand how Zydus Lifesciences performed in 2025. Let's get started.
For complete insights into Zydus Lifesciences’s incredible stock price performance and growth, see: Zydus Lifesciences Historical Share Price Data from its IPO to 2025
Table: Zydus Lifesciences Share Monthly Close, Low, High Prices for 2025
Month | Zydus Lifesciences | Change% | ↑High - ↓Low |
---|---|---|---|
Jan | ₹970.25 | - |
↑ ₹1,027.95 ↓ ₹891.15 |
Feb | ₹876.6 | -9.7% |
↑ ₹1,026.55 ↓ ₹855.1 |
Mar | ₹886.4 | 1.1% |
↑ ₹939.5 ↓ ₹859.5 |
Apr | ₹888.25 | 0.2% |
↑ ₹949.65 ↓ ₹795 |
May | ₹930 | 4.7% |
↑ ₹934 ↓ ₹859 |
Jun | ₹989.95 | 6.4% |
↑ ₹995.7 ↓ ₹917.05 |
Jul | ₹983.2 | -0.7% |
↑ ₹1,015 ↓ ₹966 |
Chart: CandleStick and Line Chart Showing Monthly Prices
[Click on line name to show/hide a line]
What if You invested ₹10,000 in Zydus Lifesciences in 2025?
In 2025, the opening price of Zydus Lifesciences share was ₹971.00. Today, the price stands at ₹983.2, reflecting a growth of 1.25%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2025 would have become ₹10,125.64 by 2025. This represents a CAGR of 1.26%.
You might also like to check: Zydus Lifesciences Stock Price in 2024
References:
Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.
Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.